We work with >280 community cancer centers & seven major academic cancer centers across the U.S., as well as 20+ top global developers of oncology therapeutics.
Of almost 3 million patient records available for research in our network, 80% are from community practices, 20% are from academic cancer centers.
Our 2,500+ employees include software engineers, data scientists, biostatisticians, epidemiologists, health professionals and other experts.
We partner with the National Cancer Institute, the U.S. Food & Drug Administration, the National Comprehensive Cancer Network® and others, and we are a founding member of the RWE Alliance.
Insights from our real-world data have helped expand treatment alternatives for people with gastric, esophageal and breast cancer, and illuminated the impact of healthcare policy on racial disparities in time to treatment.
Flatiron Health was founded in 2012 and has been an independent affiliate of the Roche Group since 2018.
Flatiron Health Real-World Data Support FDA Approval of New Dosing Regimen for ERBITUX® (cetuximab)